Divya Kamath, Ph.D

Dr. Divya Kamath is a Research Assistant Professor and Director of the Lead Development and Optimization Shared Resource at the University of Kansas Medical Center. She earned her Ph.D. in Molecular Biology and Biochemistry and completed postdoctoral training in Pulmonary and Critical Care, with a focus on Cystic Fibrosis.
Her expertise spans microbiology, molecular biology, cancer biology, inflammation, and lung physiology. She has experience in the pharmaceutical industry, specializing in drug discovery and development. Her current research focuses on developing customizable cell-free synthesis platforms for nucleic acids and proteins to support diverse downstream applications.

Our research focuses on developing a molecular biology–based toolkit to support cancer research. We utilize cell-free systems to generate nucleic acids (RNA) and/or proteins, which are then combined with nanocarrier delivery platforms to enhance cancer therapeutics and detection. Additionally, we are developing unconventional methods to produce purified proteins with human-like post-translational modifications that can be customized according to downstream applications.

Alterations in ribosomal protein L19 that decrease the fidelity of translation

Anti-apoptotic Proteolysis Targeted Chimeras (PROTACs) in Cancer Therapy

Modulation of Decoding Fidelity by Ribosomal Proteins S4 and S5

Synthesis and biological activity of novel MIF antagonists

The C-terminus of ribosomal protein uS4 contributes to small ribosomal subunit biogenesis and the fidelity of translation

Therapeutic potential of combating cancer by restoring wild-type p53 through mRNA nanodelivery